Table 1.

Survival rate after neoadjuvant radio-chemotherapy for locally advanced adenocarcinoma

Study	Adeno-carcinoma n (%)	Survival RTX	Survival Surgery	p-value
Walsh et al. 1996 [7]	113 (100%)	32% (3 y)	6% (3 y)	0.01
Urba et al. 2001 [43]	75 (75%)	30% (3 y)	16% (3 y)	0.15
Burmeister et al. 2005 [44]	158 (62%)	28% (3 y)	30% (3 y)	0.81
Tepper et al. 2008 [45]	42 (75%)	39% (5 y)	16% (5 y)	0.002
Stahl et al. 2009 [8]	119 (100%)	47.7% (3 y)	27.4%	0.07
			(CHX, 3 y)

RTX = radio-chemotherapy, CHX = chemotherapy, y = years